Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.97
USD |
NASDAQ |
Jul 31, 16:00
Cerevel Therapeutics Holdings Market Cap : 8.191B for Aug. 1, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 01, 2024 | 8.191B |
| July 31, 2024 | 8.191B |
| July 30, 2024 | 8.131B |
| July 29, 2024 | 8.091B |
| July 26, 2024 | 8.130B |
| July 25, 2024 | 8.089B |
| July 24, 2024 | 7.902B |
| July 23, 2024 | 7.907B |
| July 22, 2024 | 7.915B |
| July 19, 2024 | 7.816B |
| July 18, 2024 | 7.780B |
| July 17, 2024 | 7.783B |
| July 16, 2024 | 7.734B |
| July 15, 2024 | 7.634B |
| July 12, 2024 | 7.344B |
| July 11, 2024 | 7.479B |
| July 10, 2024 | 7.457B |
| July 09, 2024 | 7.384B |
| July 08, 2024 | 7.395B |
| July 05, 2024 | 7.463B |
| July 03, 2024 | 7.342B |
| July 02, 2024 | 7.512B |
| July 01, 2024 | 7.534B |
| June 28, 2024 | 7.450B |
| June 27, 2024 | 7.379B |
| Date | Value |
|---|---|
| June 26, 2024 | 7.098B |
| June 25, 2024 | 7.208B |
| June 24, 2024 | 7.547B |
| June 21, 2024 | 7.588B |
| June 20, 2024 | 7.594B |
| June 18, 2024 | 7.625B |
| June 17, 2024 | 7.556B |
| June 14, 2024 | 7.567B |
| June 13, 2024 | 7.577B |
| June 12, 2024 | 7.479B |
| June 11, 2024 | 7.339B |
| June 10, 2024 | 7.337B |
| June 07, 2024 | 7.291B |
| June 06, 2024 | 7.335B |
| June 05, 2024 | 7.454B |
| June 04, 2024 | 7.406B |
| June 03, 2024 | 7.403B |
| May 31, 2024 | 7.423B |
| May 30, 2024 | 7.404B |
| May 29, 2024 | 7.437B |
| May 28, 2024 | 7.470B |
| May 24, 2024 | 7.530B |
| May 23, 2024 | 7.585B |
| May 22, 2024 | 7.588B |
| May 21, 2024 | 7.610B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 397.43B |
| Amgen, Inc. | 182.27B |
| Biogen, Inc. | 28.67B |
| Gilead Sciences, Inc. | 150.88B |
| Eli Lilly & Co. | 1.072T |
Market Cap Related Metrics
| Price to Book Value | 14.51 |
| Earnings Yield | -6.07% |